clentiazem has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
| Banno, K; Kikkawa, K; Murata, S; Nagao, T; Suzuki, T; Tetsuka, T; Yamauchi, R | 1 |
2 other study(ies) available for clentiazem and Diathesis
| Article | Year |
|---|---|
Ameliorating effect of clentiazem (TA-3090), a new Ca antagonist, on the impaired learning ability of poststroke SHRSP.
Topics: Amnesia; Animals; Avoidance Learning; Calcium Channel Blockers; Cerebrovascular Disorders; Diltiazem; Disease Susceptibility; Learning Disabilities; Male; Rats; Rats, Inbred SHR | 1995 |
Effects of clentiazem on cerebral ischemia induced by carotid artery occlusion in stroke-prone spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antihypertensive Agents; Arterial Occlusive Diseases; Blood Pressure; Brain; Brain Ischemia; Carbon Dioxide; Carotid Artery Diseases; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Diltiazem; Disease Susceptibility; Electroencephalography; Energy Metabolism; Heart Rate; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Oxygen; Partial Pressure; Phosphocreatine; Rats; Rats, Inbred SHR; Regional Blood Flow; Time Factors; Tissue Distribution | 1994 |